However, emerging lawsuits claim the drug caused an eye condition called non-arteritic anterior ischemic optic neuropathy NAION
At the same time, activation of the GLP-1 receptor reduces arterial stiffness and supports endothelial function, both of which are critical factors for cardiovascular well-being (Mori et al
For Wegovy dosages, the injectable versions doses are 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg, and 7.2 mg
Nishida, K
Retatrutide has complex mechanism of the synergistic interaction among these receptors, contributes to increased insulin secretion, improved glucose homeostasis, and refined appetite modulation
Reconstituted vials should be used within 28 days of mixing